73901-41-4 Usage
Uses
Used in Organic Synthesis:
5-Pyrimidinol, 2-cyclopropyl(9CI) is used as a building block in the synthesis of various organic compounds. Its cyclopropyl-substituted pyrimidinol structure allows for the creation of novel molecules with potential applications in different industries.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-Pyrimidinol, 2-cyclopropyl(9CI) is utilized as a starting material for the development of pharmaceuticals. Its potential biological activity and unique structure make it a valuable component in the design and synthesis of new drugs.
Used in Pharmaceutical Development:
5-Pyrimidinol, 2-cyclopropyl(9CI) is employed as a key component in the development of pharmaceuticals. Its potential biological activity and ability to interact with biological targets make it a promising candidate for the creation of new therapeutic agents.
Used in Research and Exploration:
Due to its unique properties and potential applications, 5-Pyrimidinol, 2-cyclopropyl(9CI) is used as a subject of research and exploration. Scientists and researchers investigate its properties, reactivity, and potential uses to further understand its capabilities and applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 73901-41-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,9,0 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 73901-41:
(7*7)+(6*3)+(5*9)+(4*0)+(3*1)+(2*4)+(1*1)=124
124 % 10 = 4
So 73901-41-4 is a valid CAS Registry Number.
73901-41-4Relevant academic research and scientific papers
TRICYCLIC GYRASE INHIBITORS FOR USE AS ANTIBACTERIAL AGENTS
-
Paragraph 0401; 0406; 0407, (2014/04/03)
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. In addition, species of tricyclic gyrase inhibitors compounds are also disclosed herein. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
TRICYCLIC GYRASE INHIBITORS
-
Page/Page column 29, (2012/09/25)
Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.
HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS
-
Page/Page column 32, (2008/12/06)
The invention provides compounds of formula (I): wherein R1 and R2are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy. The compounds are useful as MMP inhibitors.
TRIAZOLONE DERIVATIVES AS MMP INHIBITORS FOR THE TREATMENT OF ASTHMA AND COPD
-
Page/Page column 38, (2008/06/13)
The invention provides compounds of formula (I): wherein R1, R2, R3, R4, R5, X, Y, L, G1 and m have the meanings defined in the specification; processes for their preparation; pharmaceutica
